Latest News and Press Releases

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate

New York, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The global biobanking market size is projected to expand at ~8% CAGR between 2023 and 2033. The market is expected to garner a revenue of USD 90 billion...

Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The multiplex detection immunoassays market was estimated to have acquired US$ 1.5 billion...

New York, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Research Dive states that the global multiplex assay market is anticipated to register a revenue of $4,162.5 million by 2028, at a CAGR of 5.8% during the...

New York, USA, July 20, 2021 (GLOBE NEWSWIRE) -- According to Research Dive, the global multiplex assay market is estimated to generate a revenue of $4,162.5 million by 2028, and grow at CAGR of...

HOPEWELL, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Gennao Bio, a privately held genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, today announced the...

25-year pharmaceutical industry executive brings broad drug development perspective Replaces Alberto Martinez, MD LAWRENCEVILLE, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation...

~ Financing Co-led by OrbiMed and Logos Capital to Support Advancement of Proprietary Gene Monoclonal Antibody Platform (GMAB) ~ ~ Stephen Squinto, Ph.D., Appointed Chief Executive Officer and...

LOS ANGELES, April 19, 2021 (GLOBE NEWSWIRE) -- The Global Nucleic Acid Isolation and Purification Market is expected to grow at a CAGR of around 8.8% from 2020 to 2027 and reach the market value of...